Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17250
Corporate User License Price USD 750
Corporate User License Price INR 51750
Site License Price USD 500
Site License Price INR 34500
Request a Quote

Report Title

Mithra Pharmaceuticals SA (MITRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Mithra Pharmaceuticals SA (MITRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Mithra Pharmaceuticals SA (MITRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Mithra Pharmaceuticals SA (MITRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women's health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the treatment of contraception and fertility, menopause and osteoporosis, gynecological infections and cancers, among others. Mithra offers its products in polymeric forms, sterile injectable products, and hormonal tablets. It also offers research, development and specialist manufacturing services. The company sells its products through a network of distributors in Belgium, France, Germany and Brazil, among others. Mithra is headquartered in Liege, Belgium.

Mithra Pharmaceuticals SA (MITRA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Mithra Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 10

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deal Details 13

Asset Purchase 13

Mithra Pharma Acquires Estetrol from Pantarhei Bioscience 13

Mithra Pharma Acquires Women Health Portfolio from Uteron Pharma 14

Partnerships 15

Mithra Pharma Enters into Agreement with Generic Specialty Pharma 15

Licensing Agreements 16

Pei Li Pharma Enters into Licensing Agreement with Mithra Pharma 16

Richter Gedeon Enters into Licensing Agreement with Mithra Pharma 17

Mediner Enters into Licensing Agreement with Mithra Pharma 18

Searchlight Pharma to Enter into Licensing Agreement with Mithra Pharma 19

Libbs Farmaceutica to Enter into Licensing Agreement with Mithra Pharmaceuticals 20

Fuji Pharma Enters into Licensing Agreement with Mithra Pharma for Donesta 21

Mithra Pharma Enters into Licensing Agreement for Tibelia in Canada 22

Equity Offering 23

Mithra Pharma Raises USD90 Million in Private Placement of Shares 23

Mithra Pharma Raises USD29 Million in Private Placement of Shares 25

Mithra Pharma Raises USD81.4 Million in IPO 26

Asset Transactions 27

Ceres Pharma to Acquire Women's Health Generic Business from Mithra Pharma 27

Mithra Pharmaceuticals SA-Key Competitors 28

Mithra Pharmaceuticals SA-Key Employees 29

Mithra Pharmaceuticals SA-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Financial Announcements 31

Sep 25, 2018: Mithra announces 2018 half year results 31

Mar 02, 2018: Mithra Reports 2017 Annual Results 36

Sep 21, 2017: Mithra Announces 2017 Half Year Results 41

Mar 02, 2017: Mithra Pharmaceuticals: Mithra reports 2016 annual results 42

Corporate Communications 45

Mar 03, 2017: Mithra signs agreement with Fuji Pharma to commercialise Donesta 45

Jan 19, 2017: USPTO issues Notice of Allowance for Mithra's application for Estetrol patent 46

Jan 12, 2017: Mithra Pharmaceuticals sets up scientific advisory boards for Donesta 47

Jan 06, 2017: Mithra Pharmaceuticals Appoints Christophe Marechal As Chief Financial Officer 48

Government and Public Interest 49

Feb 13, 2017: Mithra Pharmaceuticals: Mithra Granted EUR 1.9 Million In Non-Dilutive Funding 49

Product News 50

01/12/2017: Mithra's North American Advisory Board For Donesta to Meet In Miami, Florida 50

Product Approvals 51

Jun 09, 2017: Mithra Receives Orphan Drug Designation From EMA For E4 In Neonatal Encephalopathy 51

Clinical Trials 52

May 03, 2018: Mithra Announces Last Subject Visit in Estelle Phase III Study in EU/Russia and Completion of Endometrial Substudy 52

Mar 23, 2018: Mithra Announces Completion Of Estelle Cycles Required In Phase Iii Contraception Studies 53

Feb 08, 2018: Mithra Announces Very Promising Hemostasis Results for Estelle 54

Nov 30, 2017: Mithra Provides Update On Estelle Study 55

Oct 30, 2017: Mithra Completes Recruitment for Estelle Phase III Study in US & Canada 56

Oct 30, 2017: Mithra Completes Recruitment for Estelle Phase III Study in US and Canada 57

Aug 18, 2017: Mithra Announces First Subject Completes Estelle Phase III Study 58

Aug 09, 2017: Mithra Pharmaceuticals: Recruitment Completed in Estelle Population PK Substudy 59

Jul 06, 2017: Mithra Strengthens E4 Patent Position in Australian Market 60

Jun 26, 2017: Estelle Phase IIB Results on Well-Being and Body Weight Published in Leading Peer-Reviewed journal 61

Jun 21, 2017: Mithra Completes Recruitment For Additional Estelle Safety Study 62

May 12, 2017: Mithra to Initiate PK Study for Estelle 63

Feb 07, 2017: Mithra Completes Recruitment For European Phase III Estelle Study 64

Appendix 65

Methodology 65

About GlobalData 65

Contact Us 65

Disclaimer 65

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Mithra Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Mithra Pharmaceuticals SA, Deals By Therapy Area, 2012 to YTD 2018 9

Mithra Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 10

Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Mithra Pharma Acquires Estetrol from Pantarhei Bioscience 13

Mithra Pharma Acquires Women Health Portfolio from Uteron Pharma 14

Mithra Pharma Enters into Agreement with Generic Specialty Pharma 15

Pei Li Pharma Enters into Licensing Agreement with Mithra Pharma 16

Richter Gedeon Enters into Licensing Agreement with Mithra Pharma 17

Mediner Enters into Licensing Agreement with Mithra Pharma 18

Searchlight Pharma to Enter into Licensing Agreement with Mithra Pharma 19

Libbs Farmaceutica to Enter into Licensing Agreement with Mithra Pharmaceuticals 20

Fuji Pharma Enters into Licensing Agreement with Mithra Pharma for Donesta 21

Mithra Pharma Enters into Licensing Agreement for Tibelia in Canada 22

Mithra Pharma Raises USD90 Million in Private Placement of Shares 23

Mithra Pharma Raises USD29 Million in Private Placement of Shares 25

Mithra Pharma Raises USD81.4 Million in IPO 26

Ceres Pharma to Acquire Women's Health Generic Business from Mithra Pharma 27

Mithra Pharmaceuticals SA, Key Competitors 28

Mithra Pharmaceuticals SA, Key Employees 29

Mithra Pharmaceuticals SA, Subsidiaries 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Mithra Pharmaceuticals SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person